PE recurrence same with vena cava filter plus anticoagulation as anticoagulation alone | ACP Hospitalist Weekly | ACP Hospitalist
Adding an inferior vena cava filter did not reduce the risk of recurrent pulmonary embolism (PE) compared to anticoagulation alone, according to a recent study of French patients hospitalized with PE.
A 46-year-old woman with no history of pregnancy is evaluated for follow-up monitoring of pulmonary emboli that developed 13 months ago... and other cases.
Restarting anticoagulation after GI bleed associated with reduced mortality in afib | ACP Hospitalist Weekly | ACP Hospitalist
Compared to patients who didn't restart medication, those who restarted oral anticoagulation alone had a significantly increased risk of major bleeding, but the risk of recurrent GI bleeding was not significantly increased.
Details on the approval of dabigatran etexilate, and more.
New guidelines cover VTE prophylaxis, diagnosis, anticoagulation, and HIT | ACP Hospitalist Weekly | ACP Hospitalist
Several guidelines related to venous thromboembolism (VTE) prevention and treatment were recently published by the American Society of Hematology, with more promised soon.
Direct oral anticoagulation driving changes.
Extended anticoagulant treatment appears beneficial for first unprovoked PE | ACP Hospitalist Weekly | ACP Hospitalist
Eighteen months of warfarin after PE reduced recurrences during anticoagulation, but showed a similar thromboembolism rate as placebo at 42 months, a randomized trial found.
Oral anticoagulants compared for risk of recurrent VTE, major bleeds | ACP Hospitalist Weekly | ACP Hospitalist
All oral anticoagulants and antiplatelet agents reduced recurrence of venous thromboembolism (VTE) compared with placebo, with aspirin reducing risk the least and vitamin K antagonists reducing it the most, a meta-analysis found.
Details on anticoagulant regulation and more.
Score may help determine safe anticoagulation with warfarin in patients with liver disease | ACP Hospitalist Weekly | ACP Hospitalist
A 4-point score may help clinicians determine which patients with chronic liver disease can safely receive warfarin, a new study reported.